These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 11904978)

  • 21. Tissue distribution and complex formation with IgE of an anti-IgE antibody after intravenous administration in cynomolgus monkeys.
    Fox JA; Hotaling TE; Struble C; Ruppel J; Bates DJ; Schoenhoff MB
    J Pharmacol Exp Ther; 1996 Nov; 279(2):1000-8. PubMed ID: 8930210
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Omalizumab in the treatment of severe asthma: efficacy and current problems.
    Pelaia G; Renda T; Romeo P; Busceti MT; Maselli R
    Ther Adv Respir Dis; 2008 Dec; 2(6):409-21. PubMed ID: 19124386
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-immunoglobulin E therapy with omalizumab for asthma.
    Hendeles L; Sorkness CA
    Ann Pharmacother; 2007 Sep; 41(9):1397-410. PubMed ID: 17698897
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-IgE therapy of asthma.
    Chung KF
    Curr Opin Investig Drugs; 2002 Aug; 3(8):1157-60. PubMed ID: 12211407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Down-regulation of Fc(epsilon)RI expression on human basophils during in vivo treatment of atopic patients with anti-IgE antibody.
    MacGlashan DW; Bochner BS; Adelman DC; Jardieu PM; Togias A; McKenzie-White J; Sterbinsky SA; Hamilton RG; Lichtenstein LM
    J Immunol; 1997 Feb; 158(3):1438-45. PubMed ID: 9013989
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma.
    Busse W; Corren J; Lanier BQ; McAlary M; Fowler-Taylor A; Cioppa GD; van As A; Gupta N
    J Allergy Clin Immunol; 2001 Aug; 108(2):184-90. PubMed ID: 11496232
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-immunoglobulin E treatment with omalizumab in allergic diseases: an update on anti-inflammatory activity and clinical efficacy.
    Holgate ST; Djukanović R; Casale T; Bousquet J
    Clin Exp Allergy; 2005 Apr; 35(4):408-16. PubMed ID: 15836747
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of an anti-IgE humanized monoclonal antibody in ragweed-induced allergic rhinitis.
    Casale TB; Bernstein IL; Busse WW; LaForce CF; Tinkelman DG; Stoltz RR; Dockhorn RJ; Reimann J; Su JQ; Fick RB; Adelman DC
    J Allergy Clin Immunol; 1997 Jul; 100(1):110-21. PubMed ID: 9257795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-IgE antibodies for the treatment of IgE-mediated allergic diseases.
    Chang TW; Wu PC; Hsu CL; Hung AF
    Adv Immunol; 2007; 93():63-119. PubMed ID: 17383539
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-IgE therapy with omalizumab in asthma and allergic rhinitis.
    Dodig S; Richter D; Cepelak I; Benko B
    Acta Pharm; 2005 Jun; 55(2):123-38. PubMed ID: 16179127
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of high-affinity IgE receptor-mediated mast cell activation by murine low-affinity IgG receptors.
    Daëron M; Malbec O; Latour S; Arock M; Fridman WH
    J Clin Invest; 1995 Feb; 95(2):577-85. PubMed ID: 7860741
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of aerosolized anti-IgE (E25) on airway responses to inhaled allergen in asthmatic subjects.
    Fahy JV; Cockcroft DW; Boulet LP; Wong HH; Deschesnes F; Davis EE; Ruppel J; Su JQ; Adelman DC
    Am J Respir Crit Care Med; 1999 Sep; 160(3):1023-7. PubMed ID: 10471635
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-immunoglobulin E (omalizumab) therapy in allergic asthma.
    Busse WW
    Am J Respir Crit Care Med; 2001 Oct; 164(8 Pt 2):S12-7. PubMed ID: 11704612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The anti-inflammatory effects of omalizumab confirm the central role of IgE in allergic inflammation.
    Holgate S; Casale T; Wenzel S; Bousquet J; Deniz Y; Reisner C
    J Allergy Clin Immunol; 2005 Mar; 115(3):459-65. PubMed ID: 15753888
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Role of monoclonal anti-IgE antibodies (rhu-MAb) in the treatment of allergic bronchial asthma].
    Targowski T; From S
    Pol Merkur Lekarski; 2003 Jan; 14(79):65-8. PubMed ID: 12712834
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dendritic cells in normal and asthmatic airways: expression of the alpha subunit of the high affinity immunoglobulin E receptor (Fc epsilon RI -alpha).
    Tunon-De-Lara JM; Redington AE; Bradding P; Church MK; Hartley JA; Semper AE; Holgate ST
    Clin Exp Allergy; 1996 Jun; 26(6):648-55. PubMed ID: 8809422
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunological methods for quantifying free and total serum IgE levels in allergy patients receiving omalizumab (Xolair) therapy.
    Hamilton RG; Marcotte GV; Saini SS
    J Immunol Methods; 2005 Aug; 303(1-2):81-91. PubMed ID: 16045925
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Experiences with monoclonal antibody therapy for allergic asthma.
    Boushey HA
    J Allergy Clin Immunol; 2001 Aug; 108(2 Suppl):S77-83. PubMed ID: 11498677
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The pharmacological basis of anti-IgE therapy.
    Chang TW
    Nat Biotechnol; 2000 Feb; 18(2):157-62. PubMed ID: 10657120
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treating moderate-to-severe allergic asthma with anti-IgE monoclonal antibody (omalizumab). An update.
    D'Amato G; Perticone M; Bucchioni E; Salzillo A; D'Amato M; Liccardi G
    Eur Ann Allergy Clin Immunol; 2010 Aug; 42(4):135-40. PubMed ID: 21114196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.